Cipla Q1 Results: Pharma major Cipla reported a 39% year-on-year decline in Q1FY27 consolidated net profit to Rs 789 crore, mainly due to a high base, while revenue from operations rose a modest 2.3% to Rs 7,119 crore. The company’s EBITDA also declined, with margins contracting sharply compared with the year-ago quarter.
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.